Alpha Cognition Inc. Common Stock (ACOG) — Analysis Summary
Alpha Cognition Inc. Common Stock (ACOG) has a market cap of $182.47M with year-over-year revenue growth of -89.8%. Net margin stands at -202.2%. The stock trades at a P/E ratio of -7.3.
Key Takeaways
- Revenue changed -89.8% year-over-year
- Net margin of -202.2%
- P/E ratio of -7.3
Compared to other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, ACOG posted revenue growth of -89.8% and trades at a P/E of -7.3.
Alpha Cognition Inc. Common Stock (ACOG)
UPDATED — ET · SOURCE POLYGON
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Operating margin at -250.1% — severe operating losses
Net margin at -232.2% — losses exceed revenue (possible one-time charges)
The latest filing shows negative free cash flow.
Gross margin at 92.2% — verify: very few businesses sustain >90% gross margin outside pure software/IP
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
Sector
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees
71
Headquarters
GRAPEVINE, TX
Exchange
XNAS
At least 3 years of annual financial data required to assess competitive moat.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.